LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Hoskins, Clare; Cuschieri, Alfred; Wang, Lijun (2012)
Publisher: BIOMED CENTRAL LTD
Journal: JOURNAL OF NANOBIOTECHNOLOGY
Languages: English
Types: Article
Subjects: Q1, Medicine (miscellaneous), Biotechnology, Pharmaceutical Science, Biomedical Engineering, Cell membrane, Applied Microbiology and Biotechnology, Zeta potential, Atomic force microscopy, Medical technology, Research, Cell viability assay, Bioengineering, Magnetic nanoparticle, R855-855.5, Molecular Medicine, Cellular interaction, Cytotoxicity, TP248.13-248.65, R1

Classified by OpenAIRE into

mesheuropmc: technology, industry, and agriculture, macromolecular substances

Abstract

Background

Iron oxide magnetic nanoparticles (MNP's) have an increasing number of biomedical applications. As such in vitro characterisation is essential to ensure the bio-safety of these particles. Little is known on the cellular interaction or effect on membrane integrity upon exposure to these MNPs. Here we synthesised Fe3O4 and surface coated with poly(ethylenimine) (PEI) and poly(ethylene glycol) (PEG) to achieve particles of varying surface positive charges and used them as model MNP's to evaluate the relative utility and limitations of cellular assays commonly applied for nanotoxicity assessment. An alternative approach, atomic force microscopy (AFM), was explored for the analysis of membrane structure and cell morphology upon interacting with the MNPs. The particles were tested in vitro on human SH-SY5Y, MCF-7 and U937 cell lines for reactive oxygen species (ROS) production and lipid peroxidation (LPO), LDH leakage and their overall cytotoxic effect. These results were compared with AFM topography imaging carried out on fixed cell lines.

Results

Successful particle synthesis and coating were characterised using FTIR, PCS, TEM and ICP. The particle size from TEM was 30 nm (−16.9 mV) which increased to 40 nm (+55.6 mV) upon coating with PEI and subsequently 50 nm (+31.2 mV) with PEG coating. Both particles showed excellent stability not only at neutral pH but also in acidic environment of pH 4.6 in the presence of sodium citrate. The higher surface charge MNP-PEI resulted in increased cytotoxic effect and ROS production on all cell lines compared with the MNP-PEI-PEG. In general the effect on the cell membrane integrity was observed only in SH-SY5Y and MCF-7 cells by MNP-PEI determined by LDH leakage and LPO production. AFM topography images showed consistently that both the highly charged MNP-PEI and the less charged MNP-PEI-PEG caused cell morphology changes possibly due to membrane disruption and cytoskeleton remodelling.

Conclusions

Our findings indicate that common in vitro cell endpoint assays do not give detailed and complete information on cellular state and it is essential to explore novel approaches and carry out more in-depth studies to elucidate cellular response mechanism to magnetic nanoparticles.

  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Acar HYc, Garaas RS, Syud F, Bonitatebus P, Kulkarni AM: Superparamagnetic nanoparticles stabilized by polymerized PEGylated coatings. J Magn Magn Mater 2005, 293:1-7.
    • 2. Shuayev VI, Pisanic TR, Jun S: Magnetic nanoparticles for theragnostics. Adv Drug Deliver Rev 2009, 61:467-477.
    • 3. Neuberger T, Schöf B, Hofmann H, Hofmann M, von Rechenberg B: Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005, 293:483-496.
    • 4. Kralj S, Makovec D, Čampelj S, Drofenik M: Producing ultra-thin silica coatings on iron-oxide nanoparticles to improve their surface reactivity. J Magn Magn Mater 2010, 322:1847-1853.
    • 5. Tural B, Özkan N, Volkan M: Preparation and characterisation of polymer coated superparamagnetic magnetite nanoparticle agglomerates. J Phy Chem Solids 2009, 70:860-866.
    • 6. Goon IY, Lim LLMH M, Munroe P, Gooding JJ, Amal R: Fabrication and dispersion of gold-shell0protected magnetite nanoparticles: Systematic control using polyethylenimine. Chem Mater 2009, 21:673-681.
    • 7. Zablotskaya A, Segal I, Maiorov M, Zablotsky D, Mishnev A, Lukevics E, Shestakova I, Domracheva I: Synthesis and characterization of nanoparticles with an iron oxide magnetic core and a biologically active trialkylsiylated aliphatic alkanolamine shell. J Magn Magn Mater 2007, 311:135-139.
    • 8. Pisanic TR, Blackwell JD, Shubayev VI, Fiñones RR, Jin S: Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28:2572-2581.
    • 9. Ying E, Hwang H-M: In vitr evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 2010, 408:4475-4481.
    • 10. Cole AJ, Yang VC, David AE: Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol 2011, 29:323-332.
    • 11. Soenen SJ, Himmerlreich U, Nuytten N, Cuyper MD: Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 2011, 32:195-205.
    • 12. Levy M, Luciani N, Alloyeau D, Elgrabi D, Deveaux V, Pechoux C, Chat S, Wang G, Vats N, Gendron F, Factor C, Lotersztajn S, Luciani A, Wilhelm C, Gazeau F: Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 2011, 32:3988-3999.
    • 13. Becker C, Hodenius M, Blendinger G, Sechi A, Hieronymus T, MüllerSchulte D, Schmitz-Rode T, Zenke M: Uptake of magnetic nanoparticles into cells for cell tracking. J Magn Magn Mater 2007, 311:234-237.
    • 14. Sorensen M, Autrup H, Moller P, Hertel O, Jensen SS, Vinzents P, Knudsen LE, Loft S: Linking exposure to environmental pollutants with biological effects. Mutat Res 2003, 544:255-271.
    • 15. Zhu M-T, Feng W-Y, Wang B, Wang T-C, Gu Y-Q, Wang M, Wang Y, Ouyang H, Zhao Y-L, Chai Z-F: Comparative study of pulmonary responses to nano- and submicron sized ferric oxide in rats. Toxicology 2008, 247:102-111.
    • 16. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V: Biodistribution, Clearance and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats. Mol Pharm 2007, 5:316-327.
    • 17. MK Iron oxide lpoManibusan, Odin M, Eastmond DA: Postulated Carbon Tetrachloride mode of action: A Review. J Environ Sci Heal C 2007, 25:185-209.
    • 18. Fraga CG, Arias RF, Llesuy SF, Koch OR, Boveris A: Effect of vitamin E- and selenium-deficiency on rat liver chemiluminescence. Biochem J 1987, 242:383-386.
    • 19. Minotti G, Aust SD: The requirement for Iron(III) in the initiation of lipid peroxidation by Iron(II) and hydrogen peroxide. J Biol Chem 1987, 262:1098-1104.
    • 20. Arbab AS, Bashaw LA, Miller BR, Jordan AK, Lewis BK, Kalish H, Frank JA: Characterization of biophysical and metabolic properties of cells labelled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003, 229:838-846.
    • 21. Buyukhatipolu K, Clyne AM: Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A 2010, 96:186-195.
    • 22. Soenen SJ, Rivera-Gil P, Montenegro J-M, Parak WJ, De Smedt SC, Braeckmans K: Cellular toxicity of inorganic nanopartilces: Common aspects and guidelines for improved nanotoxicity evaluation. Nanotoday 2011, 6:446-465.
    • 23. Soenen SJ, Brisson AR, De Cuyper M: Addressing the problem of cationic lipid-mediated toxicity: The magnetoliposome model. Biomaterials 2009, 30:3691-3701.
    • 24. Hoskins C, Wang L, Cheng W-P, Cuschieri A: Dilemmas in the reliable estimation of the in-vitr cell viability in magnetic nanoparticle engineering: which tests and what protocols? Nanoscale Res Lett 2012, 7:77.
    • 25. Ke Y-q, Hu C-c, X-d J, Yang Z-j, Zhang H-w, Ji H-m, Zhou LY, Cai Y-q, Qin LS, Xu R-x: In vivo magnetic resonance tracking of Freidex-labeled bone marrow-derived neural stem cells after autologous transplantation in rhesus monkey. J Neurosci Meth 2009, 179:45-50.
    • 26. Drug Information Database:[http://www.drugs.com/pro/feridex.html].
    • 27. Drug Information Database:[http://www.rxlist.com/feridex_iv-drug.html].
    • 28. Dvir H, Jopp J, Gottlieb M: Estimation of polymer-surface interfacial interaction strength by a contact AFM technique. J Colloid Interf Sci 2006, 304:58-66.
    • 29. Ribero C, Brogueira P, Lvareda G, Carvalho CN, Amaral A, Santos L, Morgado J, Scherf U, Bonifácio VDB: Ultrasensitive microchip sensor based on boron-containing polyfluorene nanofilms. Biosens Bioelectron 2010, 26:1662-1665.
    • 30. Gaczynska M, Osmulski PA: AFM of biological complexes: What can we learn? Curr Opin Colloid 2008, 13:351-367.
    • 31. Franz CM, Puech P-H: Atomic force microscope: A versatile tool for studying cell morphology, adhesion and mechanics. Cell Mol Bioeng 2008, 1:289-300.
    • 32. Chen J, Hessler JA, Putchakayala K, Panama BK, Khan DP, Hong S, Mullen DG, DiMaggio SC, Som A, Tew GN, Lopatin AN, Baker JR: Banaszak Holl MM, Orr BG: Cationic nanoparticles induce nanoscale disruption in living cell plasma membrane. J Phys Chem 2009, 113:11179-11185.
    • 33. Vasir JK, Labhasetwar V: Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 2008, 29:4244-4252.
    • 34. Veiseh O, Gunn JW, Zhang M: Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliver Rev 2010, 62:284-304.
    • 35. Mailänder V, Landfester K: Interaction of Nanoparticles with cells Biomacromolecules 2009, 10:2379-2400.
    • 36. Laurent S, Forge D, Port M, et al: Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
    • 37. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA: A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 2005, 383-389.
    • 38. Aravindan L, Bicknell KA, Brooks G, Khutoryanskiy VV, Williams AC: Effect of acyl chain length on transfection efficiency and toxicity of polyethylenimine. Int J Pharm 2009, 378:201-210.
    • 39. Duan H, Nie S: Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J Am Chem Soc 2007, 129:3333-3338.
    • 40. Di Gioacchino M, Petrarca C, Lazzarin F, Di Giampaolo L, Sabbioni E, Boscolo P, Mariani-Costantini R, Bernardini G: Immunotoxicity of nanoparticles. Int J Immunopathol Pharmacol 2011, 24(1 Suppl):65S-71S.
    • 41. Andrès Vergès M, Costo R, Roca AG, Marco JF, Goya GF, Serna CJ, Morales MP: Uniform and water stable magnetite nanoparticles with diameters around the monodomain-multidomain limit. J Phys D: Appl Phys 2008, 41:1-10.
  • No related research data.
  • No similar publications.

Share - Bookmark

Published in

Funded by projects

Cite this article